Emergence of Plasmid-mediated Quinolone Resistance in Escherichia Coli in Europe

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 2004 Dec 24

PMID 15616277

Citations 94

Authors

Hedi Mammeri

Marc Van De Loo

Laurent Poirel

Luis Martinez-Martinez

Patrice Nordmann

Affiliations

Soon will be listed here.

Abstract

Although quinolone resistance results mostly from chromosomal mutations, it may also be mediated by a plasmid-encoded qnr gene in members of the family Enterobacteriaceae. Thus, 297 nalidixic-acid resistant strains of 2,700 Escherichia coli strains that had been isolated at the Bicetre Hospital (Le Kremlin-Bicetre, France) in 2003 were screened for qnr by PCR. A single E. coli isolate that carried a ca. 180-kb conjugative plasmid encoding a qnr determinant was identified. It conferred low-level resistance to quinolones and was associated with a chromosomal mutation in subunit A of the topoisomerase II gene. The qnr gene was located on a sul1-type class 1 integron just downstream of a conserved region (CR) element (CR1) comprising the Orf513 recombinase. Promoter sequences for qnr expression overlapped the extremity of CR1, indicating the role of CR1 in the expression of antibiotic resistance genes. This integron was different from other qnr-positive sul1-type integrons identified in American and Chinese enterobacterial isolates. In addition, plasmid pQR1 carried another class 1 integron that was identical to In53 from E. coli. The latter integron possessed a series of gene cassettes, including those coding for the extended-spectrum beta-lactamase VEB-1, the rifampin ADP ribosyltransferase ARR-2, and several aminoglycoside resistance markers. This is the first report of plasmid-mediated quinolone resistance in Europe associated with an unknown level of plasmid-mediated multidrug resistance in Enterobacteriaceae.

Citing Articles

Innovative approaches in phenotypic beta-lactamase detection for personalised infection management.

Lawrence J, OHare D, van Batenburg-Sherwood J, Sutton M, Holmes A, Rawson T Nat Commun. 2024; 15(1):9070.

PMID: 39433753 PMC: 11494114. DOI: 10.1038/s41467-024-53192-7.

Antimicrobial resistance of avian pathogenic isolated from broiler, layer, and breeder chickens.

Bhattarai R, Basnet H, Dhakal I, Devkota B Vet World. 2024; 17(2):480-499.

PMID: 38595648 PMC: 11000482. DOI: 10.14202/vetworld.2024.480-499.

Extended-Spectrum β-Lactamase-Producing and : Risk Factors and Economic Burden Among Patients with Bloodstream Infections.

Chen J, Allel K, Zhuo C, Luo W, He N, Yang X Risk Manag Healthc Policy. 2024; 17:375-385.

PMID: 38434551 PMC: 10909321. DOI: 10.2147/RMHP.S453686.

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities.

Husna A, Rahman M, Badruzzaman A, Sikder M, Islam M, Rahman M Biomedicines. 2023; 11(11).

PMID: 38001938 PMC: 10669213. DOI: 10.3390/biomedicines11112937.

Genetic Factors That Contribute to Antibiotic Resistance through Intrinsic and Acquired Bacterial Genes in Urinary Tract Infections.

Harris M, Fasolino T, Ivankovic D, Davis N, Brownlee N Microorganisms. 2023; 11(6).

PMID: 37374909 PMC: 10300863. DOI: 10.3390/microorganisms11061407.

References

Poirel L, Naas T, Guibert M, Chaibi E, Labia R, Nordmann P . Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum beta-lactamase encoded by an Escherichia coli integron gene. Antimicrob Agents Chemother. 1999; 43(3):573-81. PMC: 89162. DOI: 10.1128/AAC.43.3.573. View

Martinez-Martinez L, Pascual A, Jacoby G . Quinolone resistance from a transferable plasmid. Lancet. 1998; 351(9105):797-9. DOI: 10.1016/S0140-6736(97)07322-4. View

Naas T, Benaoudia F, Massuard S, Nordmann P . Integron-located VEB-1 extended-spectrum beta-lactamase gene in a Proteus mirabilis clinical isolate from Vietnam. J Antimicrob Chemother. 2000; 46(5):703-11. DOI: 10.1093/jac/46.5.703. View

Naas T, Mikami Y, Imai T, Poirel L, Nordmann P . Characterization of In53, a class 1 plasmid- and composite transposon-located integron of Escherichia coli which carries an unusual array of gene cassettes. J Bacteriol. 2000; 183(1):235-49. PMC: 94871. DOI: 10.1128/JB.183.1.235-249.2001. View

Girlich D, Poirel L, Leelaporn A, Karim A, Tribuddharat C, Fennewald M . Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol. 2001; 39(1):175-82. PMC: 87698. DOI: 10.1128/JCM.39.1.175-182.2001. View

McDonald L, Chen F, Lo H, Yin H, Lu P, Huang C . Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother. 2001; 45(11):3084-91. PMC: 90786. DOI: 10.1128/AAC.45.11.3084-3091.2001. View

Montero C, Mateu G, Rodriguez R, Takiff H . Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Antimicrob Agents Chemother. 2001; 45(12):3387-92. PMC: 90842. DOI: 10.1128/AAC.45.12.3387-3392.2001. View

Tran J, Jacoby G . Mechanism of plasmid-mediated quinolone resistance. Proc Natl Acad Sci U S A. 2002; 99(8):5638-42. PMC: 122823. DOI: 10.1073/pnas.082092899. View

Partridge S, Hall R . In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob Agents Chemother. 2002; 47(1):342-9. PMC: 149023. DOI: 10.1128/AAC.47.1.342-349.2003. View

10.

Jacoby G, Chow N, Waites K . Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother. 2003; 47(2):559-62. PMC: 151764. DOI: 10.1128/AAC.47.2.559-562.2003. View

11.

Martinez-Martinez L, Pascual A, Garcia I, Tran J, Jacoby G . Interaction of plasmid and host quinolone resistance. J Antimicrob Chemother. 2003; 51(4):1037-9. DOI: 10.1093/jac/dkg157. View

12.

Wang M, Tran J, Jacoby G, Zhang Y, Wang F, Hooper D . Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother. 2003; 47(7):2242-8. PMC: 161834. DOI: 10.1128/AAC.47.7.2242-2248.2003. View

13.

Komp Lindgren P, Karlsson A, Hughes D . Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother. 2003; 47(10):3222-32. PMC: 201150. DOI: 10.1128/AAC.47.10.3222-3232.2003. View

14.

Rodriguez-Martinez J, Pascual A, Garcia I, Martinez-Martinez L . Detection of the plasmid-mediated quinolone resistance determinant qnr among clinical isolates of Klebsiella pneumoniae producing AmpC-type beta-lactamase. J Antimicrob Chemother. 2003; 52(4):703-6. DOI: 10.1093/jac/dkg388. View

15.

Wang M, Sahm D, Jacoby G, Hooper D . Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother. 2004; 48(4):1295-9. PMC: 375335. DOI: 10.1128/AAC.48.4.1295-1299.2004. View

16.

Wang M, Sahm D, Jacoby G, Zhang Y, Hooper D . Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr. Antimicrob Agents Chemother. 2004; 48(4):1400-1. PMC: 375334. DOI: 10.1128/AAC.48.4.1400-1401.2004. View

17.

Poirel L, Heritier C, Spicq C, Nordmann P . In vivo acquisition of high-level resistance to imipenem in Escherichia coli. J Clin Microbiol. 2004; 42(8):3831-3. PMC: 497580. DOI: 10.1128/JCM.42.8.3831-3833.2004. View

18.

Kieser T . Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid. 1984; 12(1):19-36. DOI: 10.1016/0147-619x(84)90063-5. View

19.

Ambler R, Coulson A, Frere J, Ghuysen J, Joris B, Forsman M . A standard numbering scheme for the class A beta-lactamases. Biochem J. 1991; 276 ( Pt 1):269-70. PMC: 1151176. DOI: 10.1042/bj2760269. View

20.

Frohman M . Rapid amplification of complementary DNA ends for generation of full-length complementary DNAs: thermal RACE. Methods Enzymol. 1993; 218:340-56. DOI: 10.1016/0076-6879(93)18026-9. View